Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.83 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.83 |
| ▸ | PKM | P14618 | 1/20 | 0.83 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | EDNRB | P24530 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MC3R | P41968 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8392180 | 1.00 | CYP1A2 (0.83) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL8392182 | 1.00 | CYP1A2 (0.83) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL9771995 | 0.91 | CYP1A2 (0.67) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| Felbamate SCHEMBL34947 | 0.91 | CYP1A2 (1.00) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| Felbamate SCHEMBL2946508 | 0.91 | CYP1A2 (1.00) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| Felbamate SCHEMBL17597519 | 0.90 | CYP1A2 (0.96) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| Felbamate SCHEMBL7153063 | 0.90 | CYP1A2 (0.96) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL8188051 | 0.89 | CYP1A2 (0.65) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL8178310 | 0.89 | CYP1A2 (0.65) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL8177836 | 0.89 | CYP1A2 (0.65) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120083508-A1 | ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | ALLERGAN, INC. (US) | 2012-04-05 | — | — | US | disclosed |
| US-20100029618-A1 | ALPHA-2 RECEPTOR PAN AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | GIL DANIEL W | 2010-02-04 | — | — | US | disclosed |
| US-20080153874-A1 | ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | ALLERGAN INC. | 2008-06-26 | — | — | US | disclosed |
| EP-0730576-A1 | NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-09-11 | — | — | EP | disclosed |
| EP-0730575-A1 | NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996009283-A1 | NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-03-28 | — | — | WO | disclosed |
| WO-1996009284-A1 | NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083508-A1 | ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | CNR2, OPRL1, OPRD1 | CYP1A2 570/4885SMN1; SMN2 1238/4885CYP2D6 1253/4885 |
| US-20100029618-A1 | ALPHA-2 RECEPTOR PAN AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | CNR2, ADRA2A, ADRB2 | CYP1A2 446/4885SMN1; SMN2 1571/4885CYP2D6 1074/4885 |
| US-20080153874-A1 | ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN | CNR2, OPRL1, OPRD1 | CYP1A2 570/4885SMN1; SMN2 1238/4885CYP2D6 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.